| Sequence-specific recognition of HIV-1 DNA with solid-state CRISPR-Cas12a-assisted nanopores (SCAN) R Nouri*, Y Jiang*, XL Lian, W Guan ACS sensors 5 (5), 1273-1280, 2020 | 100 | 2020 |
| Detection of SARS-CoV-2 with solid-state CRISPR-Cas12a-assisted nanopores R Nouri, Y Jiang, Z Tang, XL Lian, W Guan Nano letters 21 (19), 8393-8400, 2021 | 46 | 2021 |
| Heart regeneration with human pluripotent stem cells: Prospects and challenges Y Jiang, X Lian Bioactive Materials 5 (1), 74-81, 2020 | 31 | 2020 |
| Generation of pancreatic progenitors from human pluripotent stem cells by small molecules Y Jiang, C Chen, L Randolph, S Ye, X Zhang, X Bao, X Lian Stem cell reports 16 (9), 2395-2409, 2021 | 16 | 2021 |
| An ultrasensitive calcium reporter system via CRISPR-Cas9-mediated genome editing in human pluripotent stem cells Y Jiang, Y Zhou, X Bao, C Chen, LN Randolph, J Du, XL Lian IScience 9, 27-35, 2018 | 15 | 2018 |
| STAMP-based digital CRISPR-Cas13a for amplification-free quantification of HIV-1 plasma viral loads R Nouri, Y Jiang, AJ Politza, T Liu, WH Greene, Y Zhu, JJ Nunez, X Lian, ... ACS nano 17 (11), 10701-10712, 2023 | 10 | 2023 |
| Robust genome and RNA editing via CRISPR nucleases in PiggyBac systems Y Jiang, RC Hoenisch, Y Chang, X Bao, CE Cameron, XL Lian Bioactive Materials 14, 313-320, 2022 | 9 | 2022 |
| Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells T Haideri, A Howells, Y Jiang, J Yang, X Bao, XL Lian Cell reports methods 2 (9), 2022 | 8 | 2022 |
| Stem cell engineering and differentiation for disease modeling and cell-based therapies LN Randolph*, Y Jiang*, X Lian AIMS Cell Tissue Eng 1 (2), 140-157, 2017 | 6 | 2017 |
| STAMP-Based Digital CRISPR-Cas13a (STAMP-dCRISPR) for Amplification-Free Quantification of HIV-1 Plasma Viral Load R Nouri, Y Jiang, AJ Politza, T Liu, W Greene, J Nunez, XL Lian, W Guan bioRxiv, 2022.10. 13.512138, 2022 | 1 | 2022 |
| Direct induction of hemogenic endothelial progenitors from hPSCs by defined factors revealed by single-cell transcriptome analysis LN Randolph, Y Jiang, Y Chang, X Bao, XL Lian bioRxiv, 2021.03. 18.435636, 2021 | 1 | 2021 |
| Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2 MW Ream, LN Randolph, Y Jiang, Y Chang, X Bao, XL Lian Stem Cell Reports 19 (4), 579-595, 2024 | | 2024 |
| Methods of generating hematopoietic cell preparations X Lian, LN Randolph, YQ Jiang US Patent App. 18/012,024, 2023 | | 2023 |
| Nanopore-based detection of analytes R Nouri, YQ Jiang, XL Lian, WH Guan US Patent App. 17/627,372, 2022 | | 2022 |
| Digital CRISPR-based quantification of HIV-1 R Nouri, Y Jiang, AJ Politza, XL Lian, W Guan 2022 IEEE Sensors, 1-4, 2022 | | 2022 |
| Application of human pluripotent stem cells and genetic engineering to treating and modeling pancreatic and cardiovascular degenerative diseases Y Jiang The Pennsylvania State University, 2022 | | 2022 |
| Sequence-Specific Recognition of SARS COV-2 with Solid-State CRISPR-Cas12a-Assisted Nanopores (SCAN) R Nouri, Y Jiang MicroTAS proceedings, 2021 | | 2021 |
| A dual cardiomyocyte reporter model derived from human pluripotent stem cells Y Jiang, X Bao, X Lian Stem Cell Research & Therapy 12 (305), 2021 | | 2021 |
Xiaojun Lance LianAssociate Professor, Penn State, Biomedical Engineering, BiologyVerified email at psu.edu
